Evidence map›Paper›PMID 27098689›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2016

L-Lactate-Mediated Neuroprotection against Glutamate-Induced Excitotoxicity Requires ARALAR/AGC1.

Irene Llorente-Folch, Carlos B Rueda, Irene Pérez-Liébana, Jorgina Satrústegui, Beatriz Pardo

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Mitochondrial CaBiomolecules · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Lactate promotes longevity through redox-driven lipid remodeling inbioRxiv : the preprint server for biology · 2025
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. A CaThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  16. Review
  17. Frontiers in nutrition · 2022
    Article
  18. βOHB Protective Pathways in Aralar-KO Neurons and Brain: An Alternative to Ketogenic Diet.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Irene Llorente-FolchDepartamento de Biología Molecular, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, Madrid 28049, Spain, Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid 28029, Spain, and Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid 28006, Spain.
Carlos B RuedaDepartamento de Biología Molecular, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, Madrid 28049, Spain, Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid 28029, Spain, and Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid 28006, Spain.
Irene Pérez-LiébanaDepartamento de Biología Molecular, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, Madrid 28049, Spain, Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid 28029, Spain, and Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid 28006, Spain.
Jorgina SatrústeguiDepartamento de Biología Molecular, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, Madrid 28049, Spain, Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid 28029, Spain, and Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid 28006, Spain.
Beatriz PardoDepartamento de Biología Molecular, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, Madrid 28049, Spain, Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid 28029, Spain, and Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid 28006, Spain bpardo@cbm.csic.es.
Centre for Biomedical Network Research on Rare Diseases · ESCentro de Biología Molecular Severo Ochoa · ESConsejo Superior de Investigaciones Científicas · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ARALAR/AGC1/Slc25a12, the aspartate-glutamate carrier from brain mitochondria, is the regulatory step in the malate-aspartate NADH shuttle, MAS. MAS is used to oxidize cytosolic NADH in mitochondria, a process required to maintain oxidative glucose utilization. The role of ARALAR was analyzed in two paradigms of glutamate-induced excitotoxicity in cortical neurons: glucose deprivation and acute glutamate stimulation. ARALAR deficiency did not aggravate glutamate-induced neuronal death in vitro, although glutamate-stimulated respiration was impaired. In contrast, the presence of L-lactate as an additional source protected against glutamate-induced neuronal death in control, but not ARALAR-deficient neurons.l-Lactate supplementation increased glutamate-stimulated respiration partially prevented the decrease in the cytosolic ATP/ADP ratio induced by glutamate and substantially diminished mitochondrial accumulation of 8-oxoguanosine, a marker of reactive oxygen species production, only in the presence, but not the absence, of ARALAR. In addition,l-lactate potentiated glutamate-induced increase in cytosolic Ca(2+), in a way independent of the presence of ARALAR. Interestingly,in vivo, the loss of half-a-dose of ARALAR in aralar(+/-)mice enhanced kainic acid-induced seizures and neuronal damage with respect to control animals, in a model of excitotoxicity in which increased L-lactate levels and L-lactate consumption have been previously proven. These results suggest that,in vivo, an inefficient operation of the shuttle in the aralar hemizygous mice prevents the protective role of L-lactate on glutamate excitotoxiciy and that the entry and oxidation of L-lactate through ARALAR-MAS pathway is required for its neuroprotective function. SIGNIFICANCE STATEMENT: Lactate now stands as a metabolite necessary for multiple functions in the brain and is an alternative energy source during excitotoxic brain injury. Here we find that the absence of a functional malate-aspartate NADH shuttle caused by aralar/AGC1 disruption causes a block in lactate utilization by neurons, which prevents the protective role of lactate on excitotoxicity, but not glutamate excitotoxicity itself. Thus, failure to use lactate is detrimental and is possibly responsible for the exacerbated in vivo excitotoxicity in aralar(+/-)mice.

Indexed as

AggrecansAnimalsCells, CulturedGlutamic AcidLactic AcidMaleMiceMice, 129 StrainMice, Inbred C57BLMice, TransgenicMitochondrial Membrane Transport ProteinsNeuroprotectionAcan protein, mouseAggrecansGlutamic AcidLactic AcidMitochondrial Membrane Transport ProteinsSlc25a12 protein, mouseARALAR/AGC1glutamate excitotoxicitykainic acidl-lactatemalate-aspartate NADH shuttleneuroprotection

Identifiers

PMID27098689
PMCPMC6601833
OpenAlexW2336363459

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.